Using a digital stethoscope to monitor infant heart rhythms
Effectiveness of the Eko Digital Stethoscope in Capturing Infant Electrocardiograms
This study is testing if a special digital stethoscope can help parents monitor their baby's heart rhythms at home to see if it reduces trips to the emergency room for infants with fast heartbeats.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | N/A to 1 Year |
| Sex | All |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 1 site (Richmond, Virginia) |
| Trial ID | NCT06382207 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Eko Digital Stethoscope in capturing ECGs for infants diagnosed with tachyarrhythmia. It aims to provide parents and caregivers with a tool to monitor their child's heart rhythm at home, potentially reducing unnecessary emergency room visits. The Eko DUO device, which combines a stethoscope with ECG capabilities, allows for real-time visualization of heart sounds and electrical signals through a mobile application. The study will include infants under one year of age who do not have a prior arrhythmia diagnosis.
Who should consider this trial
Good fit: Ideal candidates for this study are infants under one year of age who have not been previously diagnosed with arrhythmia.
Not a fit: Patients aged one year or older, or those with a pacemaker or ICD, will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could empower parents to monitor their infants' heart conditions more effectively, potentially reducing anxiety and healthcare costs.
How similar studies have performed: While the use of digital stethoscopes in adult populations has shown promise, this specific application in infants is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \<1 year * No previous diagnosis of arrhythmia * Parent/caregiver can provide informed consent * Parent/caregiver can speak and understand simple English Exclusion Criteria: * Age ≥ 1 year * Patient has a pacemaker or implantable cardioverter defibrillator (ICD) * Parent/caregiver is unwilling or unable to provide informed consent * Parent/caregiver is unable to speak and understand English
Where this trial is running
Richmond, Virginia
- Virginia Commonwealth University — Richmond, Virginia, United States (Recruiting)
Study contacts
- Principal investigator: Christopher Snyder — Virginia Commonwealth University
- Study coordinator: Christopher Snyder
- Email: christopher.snyder@vcuhealth.org
- Phone: 8046284787
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.